tradingkey.logo
tradingkey.logo
Suchen

Clearpoint Neuro Inc

CLPT
Zur Watchlist hinzufügen
18.720USD
0.0000.00%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
561.35MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Clearpoint Neuro Inc Unternehmen

ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.

Clearpoint Neuro Inc Informationen

BörsenkürzelCLPT
Name des UnternehmensClearpoint Neuro Inc
IPO-datumJul 03, 2019
CEOBurnett (Joseph Michael)
Anzahl der mitarbeiter115
WertpapierartOrdinary Share
GeschäftsjahresendeJul 03
Addresse120 S. Sierra Avenue
StadtSOLANA BEACH
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92075
Telefon19499006833
Websitehttps://www.clearpointneuro.com/
BörsenkürzelCLPT
IPO-datumJul 03, 2019
CEOBurnett (Joseph Michael)

Führungskräfte von Clearpoint Neuro Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--
Mr. R. John Fletcher
Mr. R. John Fletcher
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. B. Kristine (Kris) Johnson
Ms. B. Kristine (Kris) Johnson
Independent Director
Independent Director
--
--
Mr. Danilo D' Alessandro
Mr. Danilo D' Alessandro
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Linda M. Liau
Dr. Linda M. Liau
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Joseph Michael Burnett
Mr. Joseph Michael Burnett
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
310.07K
--
Mr. Timothy T. Richards
Mr. Timothy T. Richards
Independent Director
Independent Director
87.32K
-6.06%
Mr. Mazin Sabra
Mr. Mazin Sabra
Chief Operating Officer
Chief Operating Officer
67.34K
+33.96%
Ms. Lynnette C. Fallon
Ms. Lynnette C. Fallon
Independent Director
Independent Director
48.23K
+15.19%
Dr. Matthew B. Klein, M.D.
Dr. Matthew B. Klein, M.D.
Independent Director
Independent Director
46.94K
-7.63%
Mr. Pascal E.R. Girin
Mr. Pascal E.R. Girin
Independent Director
Independent Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Clearpoint Neuro Inc?

Die fünf größten Anteilseigner von Clearpoint Neuro Inc sind: Mr. Joseph Michael Burnett

Wie viele Institutionen halten Anteile an Clearpoint Neuro Inc (CLPT)?

Mit Stand vom 2026Q1 halten 266 Institutionen Anteile an Clearpoint Neuro Inc, mit einem Gesamtmarktwert von etwa 15.83M, was 52.78% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um 1860542.00 gestiegen.

Was ist die größte Einnahmequelle von Clearpoint Neuro Inc?

Am 2026Q1 erzielte das Geschäft mit Products: Functional neurosurgery für Clearpoint Neuro Inc den höchsten Umsatz in Höhe von 14.83M, was 40.12% des Gesamtumsatzes entspricht.